Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
The Balancing Act

Jul 1, 2016/Column

That's just what it is-an act. There's a better way.

Potential Fee Schedule Reprieve Introduced in U.S. House

Sep 14, 2022/News

A bipartisan bill would provide money to offset anticipated 2023 Medicare Physician Fee Schedule payment cuts.

Interventions for Breast Cancer–Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA (CPG+)

Jul 1, 2020/CPG

The Academy of Oncologic Physical Therapy of APTA published its first major treatment-related clinical practice guideline — a resource on treatment of lymphedema related to breast cancer targeted specifically at the PT's role.

Coronavirus Update: August 24

Aug 24, 2022/Roundup

Physical activity's role in reducing COVID-19 risk, prone positioning, new CDC recommendations, home testing, and more.

CMS Takes Aim at Prior Authorization in Medicaid, CHIP, and Federal Exchanges

Jan 19, 2021/Review

The final rule pushes payers toward more transparency and consistent deadlines for decisions.

Serving Survivors

Apr 1, 2019/Feature

From pediatrics through palliative care, PTs and PTAs are playing important roles in improving the lives of survivors of cancer. Other health professions are taking notice and endorsing their efforts.

APTA Financial Solutions Center Faculty Toolkit

Jan 12, 2021/Resource

Start your students on a path toward better financial security and a more rewarding career in physical therapy with these financial solution tools, resources, and information.

Coronavirus and Long COVID Update, October 2023

Oct 23, 2023/Roundup

SSRIs and Long COVID, Post-COVID-19 organ abnormalities, lingering symptoms among children, and more.

Legal Topics of Interest

Aug 1, 2019/Article

PTs and PTAs practice in an environment that requires compliance with health care laws, rules, and regulations.

Coronavirus Update: April 19

Apr 19, 2023/Roundup

What to know about the end of the PHE, risk associations for long COVID, funding for long COVID clinic innovation, and more.